García-Alix Neonatal Encephalopathy Rating Scale

Reference scale for structured neonatal-encephalopathy assessment.

What is García-Alix Neonatal Encephalopathy Rating Scale?

García-Alix NE-RS for structured neonatal encephalopathy assessment, with original source, population, evidence and limitations.

Population and scope

Neonatal Encephalopathy. Newborns with neonatal encephalopathy

Also searched as

García-Alix NE-RS · garcia-alix · neonatal encephalopathy · Garcia Alix scale · neonatal encephalopathy rating scale · encefalopatia neonatal

Calculator available

This page has an active local calculator in PedsCore. Entered values are processed in the browser, with references, limits and interpretation shown alongside the result.

Open calculator

Clinical use

This PedsCore page brings together clinical information, implementation status and available evidence for García-Alix Neonatal Encephalopathy Rating Scale. It is intended for Newborns with neonatal encephalopathy. The tool belongs to Neonatology and should be interpreted in the appropriate clinical context.

Interpretation and validation

Complete García-Alix NE-RS: 7 clinical items + 2 aEEG items, asymmetric 0-70 score, validated within the first 6 hours after birth.

PedsCore does not replace clinical judgement. Scores, rules and calculators are presented with evidence traceability and a visible implementation status.

Clinical review and maintenance

Implementation review and independent clinical review are shown separately. PedsCore does not attribute named reviewers or external endorsement without a public record supporting the claim. The repository preserves source, change and test history.

Editorial transparency

This page is part of an open-source project. Evidence level, implementation status, validation notes and sources are shown explicitly. It currently contains 2 catalog references. Content and calculation changes are reviewed through the public repository, automated tests and version traceability.

The absence of an active calculator is not a clinical recommendation: some tools remain reference-only while source, licensing, exact variant or validation still require review.

Each page lets you verify what is being assessed, which population the tool describes, whether local calculation is available, which limitations remain open and which references support implementation. This context matters when different publications, versions or adaptations share a similar name but are not interchangeable.